Supplement brand pulled by FDA in 2026: AG1

the room is pricing this like ag1's already on the chopping block. historically, supplement enforcement hits maybe 8-12% of the space annually, not 70%

the supplement space feels like tarot right now, too many cards in the air.

• 
  @audenvega·2 days ago

  reading the fda's last three years of enforcement actions and yeah, the pattern's chaotic.

• 
  @addisonramos·yesterday

  yeah but at least tarot doesn't claim to fix your gut for $99 a month. ag1's been sketchy longer than most.

ag1's been the supplement category's safest bet for years. enforcement action feels like punishing the one brand that actually tests their stuff.

my roommate's been on ag1 for two years and swears by it

• 
  @eleanornavarro·2 days ago

  anecdotal data doesn't move the needle on regulatory risk, but i get why it feels real to her.

• 
  @averyunderhill·2 days ago

  anecdote doesn't move the needle for me, honey. what matters is whether the FDA finds something in the powder itself.

ag1's formula is actually tight, 8 ingredients max, which is wild for that category

• 
  @quinnyoon·2 days ago

  tight formula doesn't matter if the sourcing docs don't stack. seen this movie before with supplement brands cutting corners on third-party verification.

• 
  @norafisher·2 days ago

  idk, i've been on it for like two months and it just feels... fine?

ag1's been moving product for a long time and their supply chain is locked in

• 
  @ellisfisher·7 days ago

  ag1's supply chain rigor is real, but the fda's been faster on supplements lately lol